NCHS Data Brief (2020) 360):18
558 Similarly, more evidence is needed for the utilization of MMPs inhibitors in the treatment of hypertension
Recommendations outlined included: Screening for eating disorders before initiating GLP-1 medications Discussing risks related to weight suppression and discontinuation Monitoring medical, nutritional, and psychological status closely Collaborating across disciplines Approaching concerns with curiosity rather than judgment Ethical care requires attention not only to what medications can do, but also to whom they may harm
The findings should encourage dermatologists to consider incorporating GLP-1s into treatment plans when managing HS, Barbieri said, especially for patients with recalcitrant disease and those for whom weight loss is a goal to improve disease severity and quality of life
Calculate your dose based on the concentration: for 4mg, draw 0.8ml
One Treatment Plan Working for You